摘要
背景:神经炎症在阿尔茨海默病(AD)等多种神经退行性疾病的发病机制中起着重要作用,细胞因子信号传导3(SOCS 3)抑制剂是一种抑制包括小胶质细胞在内的多种细胞内细胞因子信号和炎症基因表达的抗炎分子。 目的:SOCS 3的上调途径尚不清楚,肉桂酸是肉桂的代谢产物,是一种天然化合物,在世界范围内被广泛用作香料或调味剂,本文研究了肉桂酸是否能在小胶质细胞中上调SOCS 3的含量。 方法:用肉桂酸处理小鼠脑内分离的小胶质细胞和星形胶质细胞,用RT-PCR和实时定量PCR检测SOCS 3和不同促炎分子的水平,并进行芯片分析,监测SOCS 3基因启动子上cAMP反应元件结合(CREB)的形成,并对CREB进行siRNA基因敲除。 结果:肉桂酸可上调小鼠BV-2小胶质细胞SOCS 3 mRNA和蛋白的表达,与BV-2小胶质细胞相似,相应地,肉桂酸还能增加LPS刺激的bv-2小胶质细胞的SOCS 3水平,抑制诱导型一氧化氮合酶和促炎细胞因子(TNF-α、IL-1β和IL-6)的表达。与BV-2小胶质细胞相似,肉桂酸也增加了原代小鼠小胶质细胞和星形胶质细胞中SOCS 3的表达。我们已经观察到SOCS 3基因启动子中存在cAMP反应元件,肉桂酸诱导CREB活化,siRNA敲除CREB可使肉桂酸介导的SOCS 3上调,肉桂酸处理导致CREB进入SOCS 3基因。 结论:肉桂酸通过CREB途径上调胶质细胞SOCS 3的表达,可能在神经炎症和神经退行性疾病中起重要作用。
关键词: 肉桂酸、胶质细胞、细胞因子信号抑制物、环磷腺苷效应元件结合蛋白、神经炎症、小胶质细胞。
Current Alzheimer Research
Title:Upregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid
Volume: 15 Issue: 10
关键词: 肉桂酸、胶质细胞、细胞因子信号抑制物、环磷腺苷效应元件结合蛋白、神经炎症、小胶质细胞。
摘要: Background: Neuroinflammation plays an important role in the pathogenesis of various neurodegenerative diseases including Alzheimer’s disease (AD). Suppressor of cytokine signaling 3 (SOCS3) is an anti-inflammatory molecule that suppresses cytokine signaling and inflammatory gene expression in different cells including microglia.
Objective: The pathways through which SOCS3 could be upregulated are poorly described. Cinnamic acid is a metabolite of cinnamon, a natural compound that is being widely used all over the world as a spice or flavoring agent. Here, we examined if cinnamic acid could upregulate SOCS3 in microglia.
Method: Microglia and astroglia isolated from mouse brain as well as BV-2 microglial cells were treated with cinnamic acid followed by monitoring the level of SOCS3 and different proinflammatory molecules by RT-PCR and real-time PCR. To nail down the mechanism, we also performed ChIP analysis to monitore the recruitment of cAMP response element binding (CREB) to the socs3 gene promoter and carried out siRNA knockdown of CREB.
Results: Cinnamic acid upregulated the expression of SOCS3 mRNA and protein in mouse BV-2 microglial cells in dose- and time-dependent manner. Accordingly, cinnamic acid also increased the level of SOCS3 and suppressed the expression of inducible nitric oxide synthase and proinflammatory cytokines (TNFα, IL-1β and IL-6) in LPSstimulated BV-2 microglial cells. Similar to BV-2 microglial cells, cinnamic acid also increased the expression of SOCS3 in primary mouse microglia and astrocytes. We have seen that cAMP response element is present in the promoter of socs3 gene, that cinnamic acid induces the activation of CREB, that siRNA knockdown of CREB abrogates cinnamic acid-mediated upregulation of SOCS3, and that cinnamic acid treatment leads to the recruitment of CREB to the socs3 gene.
Conclusions: These studies suggest that cinnamic acid upregulates the expression of SOCS3 in glial cells via CREB pathway, which may be of importance in neuroinflammatory and neurodegenerative disorders.
Export Options
About this article
Cite this article as:
Upregulation of Suppressor of Cytokine Signaling 3 in Microglia by Cinnamic Acid, Current Alzheimer Research 2018; 15 (10) . https://dx.doi.org/10.2174/1567205015666180507104755
DOI https://dx.doi.org/10.2174/1567205015666180507104755 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
NK-1 Receptor Antagonists: A New Paradigm in Pharmacological Therapy
Current Medicinal Chemistry Meet the Editorial Board
Current HIV Research TREM2 and the Progression of Alzheimer’s Disease
Current Neurovascular Research The Impact of Dementia Development Concurrent with Parkinson's Disease: A New Perspective
CNS & Neurological Disorders - Drug Targets Neurotrophic Factors as a Protective Strategy in Parkinsons Disease
CNS & Neurological Disorders - Drug Targets The Effects of Soluble Aβ Oligomers on Neurodegeneration in Alzheimer's Disease
Current Pharmaceutical Design Editorial (Thematic Issue: GABAergic Modulation as Treatment Strategy: Consideration of Several Diseases)
Current Pharmaceutical Design Current Progresses on Nanodelivery Systems for the Treatment of Neuropsychiatric Diseases: Alzheimer’s and Schizophrenia
Current Pharmaceutical Design A Systematic, Updated Review on the Antidepressant Agomelatine Focusing on its Melatonergic Modulation
Current Neuropharmacology Poly(ADP-Ribose)Polymerase 1 (PARP-1) Activation and Ca<sup>2+</sup> Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid (AMPA) Channels in Post-Ischemic Brain Damage: New Therapeutic Opportunities?
CNS & Neurological Disorders - Drug Targets Chaperonopathies and Chaperonotherapy. Hsp60 as Therapeutic Target in Cancer: Potential Benefits and Risks
Current Pharmaceutical Design Gastric Inhibitory Polypeptide and its Receptor are Expressed in the Central Nervous System and Support Neuronal Survival
Central Nervous System Agents in Medicinal Chemistry Radiolabelled Quinoline Derivaties for the PET Imaging of Peripheral Benzodiazepine Receptor
Current Medical Imaging Alcohol Use Disorder and Dementia: Critical Mechanisms for Cognitive Loss
Current Neurovascular Research Review of Synthesis, Assay, and Prediction of β and γ-secretase Inhibitors
Current Topics in Medicinal Chemistry A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer’s Disease
Current Medicinal Chemistry Endogenous Retroelements in Cellular Senescence and Related Pathogenic Processes: Promising Drug Targets in Age-Related Diseases
Current Drug Targets Kynurenine Pathway and Disease: An Overview
CNS & Neurological Disorders - Drug Targets QSAR and Molecular Docking Techniques for the Discovery of Potent Monoamine Oxidase B Inhibitors: Computer-Aided Generation of New Rasagiline Bioisosteres
Current Topics in Medicinal Chemistry Effects of Memantine on Event-Related Potentials in Alzheimer’s Disease Under Donepezil Treatment
Neuroscience and Biomedical Engineering (Discontinued)